Clinical Trial

Supraglottic Jet Oxygenation Ventilation During Hysteroscopic Surgery

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated March 3, 2026 (before its estimated March 20, 2026 completion). Its status may not reflect the trial's current state.
Summary
Hysteroscopic surgery is widely used in the diagnosis and treatment of gynecological diseases. Because its operation process can cause anxiety and pain in patients, it needs to be performed under anesthesia. At present, patients under conventional non-intubation general anesthesia are prone to respiratory depression and hypoxemia. Supraglottic jet oxygen supply and ventilation (SJOV) technology can provide reliable oxygen supply and ventilation for patients with respiratory arrest and respiratory depression. It can assist in completing difficult tracheal intubation, especially in emergency airway situations where "intubation and ventilation cannot be performed". It can effectively avoid catastrophic outcomes and also prevent and reduce hypoxemia in patients undergoing day surgery. However, there are very few studies on hysteroscopic surgery. This study intends to design a single-center randomized controlled study. Patients scheduled for elective hysteroscopic surgery were randomly divided into two groups: the conventional nasal catheter ventilation group and the SJOV group. The feasibility of supraglottic jet oxygenation ventilation in hysteroscopic surgery was studied through different airway management methods. The primary outcome measure was the incidence of intraoperative hypoxemia (75%≤SpO2\<90%, ≤60 seconds), and the secondary outcome measures were subclinical respiratory depression, sore throat and other adverse events. The expected result is that supragttic jet ventilation can improve the incidence of hypoxia in patients during hysteroscopy, reduce sore throat or other complications at the same time, promote patient recovery, and improve patient satisfaction.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-30.
Trial Details
NCT Number NCT07110428
Lead Sponsor Peking University Shenzhen Hospital
Conditions Hysteroscopic Surgery
Enrollment 100 participants
Start Date 2025-07-03
Primary Completion 2026-03-20 (estimated)
Study Completion 2026-03-20 (estimated)
Updated on ClinicalTrials.gov 2026-03-03